Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

A significant, non-obvious downside of AI's impact is its potential to radically improve healthcare and extend lifespans. While great for humanity, this directly burdens the federal budget. Longer lives mean more years of drawing Social Security and Medicare benefits, significantly increasing the long-term unfunded liabilities of these entitlement programs.

Related Insights

As companies replace human workers with AI 'robots,' they eliminate a crucial source of government funding: payroll taxes. This trend threatens the solvency of programs like Social Security, which rely on a large base of human workers to support a growing retiree population.

Dr. Wachter warns that unless payment models change, AI will be used to maximize revenue, not lower costs. If the system rewards doing more or using more expensive treatments, AI decision support will guide clinicians toward those choices, potentially inflating the overall cost of care despite efficiency gains.

The AI industry and the US government both require trillions in funding. This creates a paradox: the more successful AI becomes, the more it erodes the white-collar tax base by automating jobs, forcing the Treasury to borrow even more and intensifying the competition for scarce capital.

The ability of Western governments to manage their enormous public debt levels is now implicitly dependent on the hope that AI will generate a massive, sustained productivity boom. If AI fails to deliver this unprecedented growth, a widespread fiscal crisis becomes a serious risk.

By extending citizens' "healthspan," the demand for expensive late-stage Medicare services decreases. This argument reframes longevity from a purely medical issue to a key strategy for fiscal conservatives focused on reducing government spending.

Anti-aging treatments will pay for themselves by eliminating the enormous medical costs of late-life health problems. This creates a powerful economic imperative for governments to ensure universal access, countering the common fear that such therapies will only be available to the wealthy.

The economic benefit of longevity, termed the "longevity dividend," is massive. Each additional year of healthy, productive life adds trillions of dollars to the GDP. This economic argument justifies significant government and private investment into aging research, as the societal ROI is immense.

The US can grow its way out of its mounting fiscal problems through AI-driven productivity. This creates real growth without wage inflation, expands the corporate tax base, and offsets a poor demographic outlook. This is the most viable path for the US to avoid a fiscal cliff.

While an AI productivity boom could significantly reduce the US primary deficit, economist Ben Harris argues this optimism must be tempered. His model shows that five factors—longer life spans, lower labor participation, a shift to lower-taxed capital income, an AI arms race, and higher interest rates—will erase roughly half the fiscal gains from growth.

Reactive healthcare systems like US Medicare are financially unsustainable against an aging population, with projections for insolvency by 2035. The only viable path forward is a government-led pivot from reactive disease treatment to proactive, preventative longevity technologies to manage costs and improve healthspan.

AI's Biggest Healthcare Win—Longer Lives—Worsens the US Fiscal Crisis | RiffOn